| Post |
| Pre |
| LA |
|---|
| 0.7 |
| 1.3 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.4 | 3.2 | 5.7 | 3.1 | 1.3 | 2.4 | - | - | - | - | 22.2 |
| 1.5 | 0.4 | 1.2 | 1 | 2.3 | 2.4 | - | - | - | - | 8.8 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 707 | 92.2% | -1.99 | 178 | 86.0% |
| Optic-unspecified(R) | 58 | 7.6% | -1.21 | 25 | 12.1% |
| LA(R) | 2 | 0.3% | 1.00 | 4 | 1.9% |
| upstream partner | # | NT | conns R7R8_unclear | % In | CV |
|---|---|---|---|---|---|
| Dm9 (R) | 21 | Glu | 5.0 | 77.7% | 1.1 |
| Tm5c (R) | 2 | Glu | 0.3 | 4.4% | 0.8 |
| L3 (R) | 15 | ACh | 0.3 | 4.4% | 0.7 |
| R7R8_unclear | 9 | HA | 0.2 | 3.8% | 0.7 |
| C2 (R) | 6 | GABA | 0.2 | 3.3% | 0.7 |
| R8_unclear | 8 | HA | 0.2 | 3.1% | 0.8 |
| Mi1 (R) | 2 | ACh | 0.1 | 1.1% | 0.7 |
| Tm20 (R) | 1 | ACh | 0.0 | 0.5% | 0.0 |
| Mi14 (R) | 1 | Glu | 0.0 | 0.4% | 0.0 |
| Mi15 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| MeLo1 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| l-LNv (R) | 1 | unc | 0.0 | 0.2% | 0.0 |
| aMe30 (R) | 1 | Glu | 0.0 | 0.2% | 0.0 |
| Mi18 (R) | 1 | GABA | 0.0 | 0.2% | 0.0 |
| Dm11 (R) | 1 | Glu | 0.0 | 0.2% | 0.0 |
| L2 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| downstream partner | # | NT | conns R7R8_unclear | % Out | CV |
|---|---|---|---|---|---|
| Dm9 (R) | 17 | Glu | 1.2 | 22.0% | 0.9 |
| Tm20 (R) | 20 | ACh | 0.5 | 9.5% | 0.6 |
| Mi4 (R) | 14 | GABA | 0.5 | 8.7% | 0.9 |
| Dm8b (R) | 15 | Glu | 0.4 | 7.6% | 0.9 |
| Mi1 (R) | 17 | ACh | 0.4 | 7.6% | 0.5 |
| Tm5c (R) | 11 | Glu | 0.3 | 5.7% | 0.8 |
| L3 (R) | 14 | ACh | 0.3 | 5.5% | 0.7 |
| R7R8_unclear | 9 | HA | 0.2 | 4.4% | 0.7 |
| L1 (R) | 12 | Glu | 0.2 | 4.2% | 0.4 |
| MeLo1 (R) | 7 | ACh | 0.2 | 4.2% | 0.5 |
| Mi15 (R) | 9 | ACh | 0.1 | 2.5% | 0.5 |
| MeTu3c (R) | 3 | ACh | 0.1 | 2.3% | 0.6 |
| Dm2 (R) | 8 | ACh | 0.1 | 2.3% | 0.5 |
| aMe12 (R) | 2 | ACh | 0.1 | 1.9% | 0.3 |
| Tm5b (R) | 3 | ACh | 0.1 | 1.7% | 0.4 |
| Mi9 (R) | 4 | Glu | 0.1 | 1.3% | 0.3 |
| C2 (R) | 1 | GABA | 0.0 | 0.8% | 0.0 |
| Dm-DRA2 (R) | 2 | Glu | 0.0 | 0.8% | 0.0 |
| MeVP11 (R) | 2 | ACh | 0.0 | 0.8% | 0.5 |
| Dm8a (R) | 2 | Glu | 0.0 | 0.6% | 0.3 |
| Tm29 (R) | 1 | Glu | 0.0 | 0.4% | 0.0 |
| MeVPLp1 (R) | 1 | ACh | 0.0 | 0.4% | 0.0 |
| Tm5a (R) | 1 | ACh | 0.0 | 0.4% | 0.0 |
| Dm11 (R) | 2 | Glu | 0.0 | 0.4% | 0.0 |
| T1 (R) | 2 | HA | 0.0 | 0.4% | 0.0 |
| Cm2 (R) | 2 | ACh | 0.0 | 0.4% | 0.0 |
| Lawf1 (R) | 2 | ACh | 0.0 | 0.4% | 0.0 |
| MeLo2 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| Tm3 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| Cm11d (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| Tm4 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| Cm4 (R) | 1 | Glu | 0.0 | 0.2% | 0.0 |
| Mi14 (R) | 1 | Glu | 0.0 | 0.2% | 0.0 |
| Tm26 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| Tm6 (R) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| aMe30 (R) | 1 | Glu | 0.0 | 0.2% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 0.0 | 0.2% | 0.0 |
| R7_unclear | 1 | HA | 0.0 | 0.2% | 0.0 |